Adam M. Freiman is a leading corporate lawyer who possesses a deep understanding of the emerging company ecosystem and technology market in New York. His knowledge and ability to serve the vast needs of today’s most innovative companies, including those in the technology, healthcare and media industries, is backed by his 20 years of experience in handling the complex business transactions and legal issues they face.
As a partner in the firm’s Corporate and Emerging Company and Venture Capital Practices, Mr. Freiman offers solutions-focused, strategic advice and an indispensable business perspective that is critical to clients’ success.
Mr. Freiman works closely with a wide range of companies at all stages of their life cycle, from incorporation to exit. He advises high-growth companies on a diverse range of critical transactions, including seed, angel, venture capital and strategic financings; IPOs and other public offerings; and mergers and acquisitions.
He also advises clients on complex securities matters, corporate governance matters, joint ventures and strategic transactions. In addition, Mr. Freiman has extensive experience representing venture capital funds and other investors.
Mr. Freiman also has experience representing both issuers and underwriters in connection with public offerings, private placement transactions, and exchange and tender offers, as well as advising public company clients on SEC reporting and disclosure requirements.
Prior to joining WilmerHale, Mr. Freiman spent the last 10 years as a partner in the New York offices of two AmLaw100 firms.